Publicaciones en colaboración con investigadores/as de Universidad Pública de Navarra (12)

2022

  1. Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers

    Theranostics, Vol. 12, Núm. 3, pp. 1373-1387

2021

  1. CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

    Nature Communications, Vol. 12, Núm. 1

  2. Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11

  3. Olfactory Characterization and Training in Older Adults: Protocol Study

    Frontiers in Aging Neuroscience, Vol. 13

  4. Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma

    Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337

2019

  1. Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy

    Journal of Proteomics, Vol. 194, pp. 168-178

2018

  1. Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection

    Oncotarget, Vol. 9, Núm. 57, pp. 31045-31065

2016

  1. Evaluation of a Salmonella strain lacking the secondary messenger C-di-GMP and RpoS as a live oral vaccine

    PLoS ONE, Vol. 11, Núm. 8

2009

  1. Estradiol induces type 8 17β-hydroxysteroid dehydrogenase expression: Crosstalk between estrogen receptor α and C/EBPβ

    Journal of Endocrinology, Vol. 200, Núm. 1, pp. 85-92

2007

  1. Transcriptional regulation of the human type 8 17β-hydroxysteroid dehydrogenase gene by C/EBPβ

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 105, Núm. 1-5, pp. 131-139

2004

  1. Seroprevalencia de hepatitis A en Navarra

    Revista Clinica Espanola, Vol. 204, Núm. 3, pp. 145-150

2001

  1. New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells

    British Journal of Cancer, Vol. 85, Núm. 9, pp. 1400-1402